Unique approach

While each of the PharmaFutures initiatives is distinct, the common thread is the investor-led discussion focused on identifying long-term value creation opportunities that will yield enhanced public health outcomes. The project approach began with a scenario-planning exercise and has increasingly become more granular, exploring key value drivers for the pharmaceutical industry and identifying potential new models for expanding access to healthcare in emerging markets, including China, Brazil and India.

Visit these links to learn more about PharmaFutures’ unique approach:


The industry’s social contract is under severe strain. There is an urgent need for new treatments for antibiotics and diseases like Alzheimer’s. It is in the interest of patients, healthcare providers, industry and pension holders to work together to create the best model for bringing new drugs to market.

Sophia Tickell, Director, PharmaFutures